Received Apr 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y008592 | SC / LA |
04/03/25 ? Patient called to report pain and itching at the injection site. Immunization was administered on 02/26/25, with symptoms first appearing on 03/23/25. Patient reports noticing two injection sites on the posterior aspect of the arm. After consultation with RN, it was confirmed that only one vaccine was administered. Patient states symptoms were severe enough to seek care at the ER on 03/30/25, where he received IV Rocephin and an intramuscular injection of Toradol. A prescription for Keflex was also provided. The rash was outlined at the ER on 03/30/25 for monitoring. However, the rash extended beyond the outline, prompting a return visit to the ER on 04/01/25. Patient reports that the ER physician was dismissive and advised him to complete the Keflex course. After speaking with the patient, this RN reassured him that only one vaccine had been administered and informed him that a VAERS report would be submitted. Patient reports rash is now subsiding, with minimal pain and itching remaining.
hashimoto disease